Browse press releases
The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.
- Big Pharma Setbacks Create a New Wave of Rebound PlaysThe biotech space is ripe with attractive rebound setups. $NVS, $NTHI, $TNON, $IRD, $LLY, $AMGN, and $BIAF
- The Law Offices of Frank R. Cruz, Los AngelesAardvark Therapeutics, Inc. (AARD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud LawsuitThe Law Offices of Frank R. Cruz announces that investors with losses related to Aardvark Therapeutics, Inc. (AARD) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN AARDVARK...
- Cullinan Therapeutics to Host Virtual Analyst and Investor Event to Showcase Zipalertinib Plus Chemotherapy Phase 3 REZILIENT3 Data Presented at the IASLC 2026 World Conference on Lung CancerResults from the planned interim analysis of the Phase 3 REZILIENT3 trial of zipalertinib plus chemotherapy in first-line EGFR exon 20 insertion mutation NSCLC to be presented in Presidential Symposium 2 on Sunday, September 13, 2026
- OpenAIHow a researcher uses Codex and ChatGPT to search for new antimicrobial moleculesCompanies: OpenAICésar de la Fuente’s lab uses Codex and ChatGPT to search living and extinct genomes for antimicrobial candidates to fight drug-resistant infections.
- ABEC Opens New Manufacturing Facility in Wilson, North CarolinaGrand Opening Ceremony Scheduled for September 24, 2026 — ABEC, a global leader in customized solutions and services for biopharmaceutical manufacturing, today announced the grand opening of its newest manufacturing facility in Wilson, North...
- NYU Langone Perlmutter Cancer CenterNYU Langone Health's Perlmutter Cancer Center Appoints New Vice Chair of Physics and Dosimetry in the Department of Radiation OncologyNYU Langone Health's Perlmutter Cancer Center has appointed Sean L. Berry, PhD, as vice chair of physics and dosimetry in the Department of Radiation Oncology. Dr. Berry brings more than 20 years of experience in radiation oncology physics, with...
- Zealand Pharma increases its share capital as a result of the exercise of employee warrantsCompany announcement – No. 47 / 2026
- Toronto Stock ExchangeLe Pediatric Oncology Group of Ontario (POGO) ouvre les marchésToronto, Ontario--(10 septembre 2026) - Lauren Ettin, chef de la direction du Pediatric Oncology Group of Ontario (POGO), et son équipe se sont joints à John McKenzie, chef de la direction du Groupe TMX, pour ouvrir les marchés et souligner l'événement « Sonner la cloche » de TMX en appui au POGO. Cette activité de bienfaisance, qui combine marche, course et cyclisme, permet d'amasser des fonds pour appuyer le POGO et sa mission.Cannot view this video? ...
- Toronto Stock ExchangePediatric Oncology Group of Ontario (POGO) Opens the MarketLauren Ettin, Chief Executive Officer, Pediatric Oncology Group of Ontario (POGO), and her team joined John McKenzie, Chief Executive Officer, TMX Group, to open the market and celebrate TMX Ring the Bell in support of POGO. This walking, running and cycling charity event raises funds for POGO and its mission.Cannot view this video? Visit:https://www.youtube.com/watch?v=qWvcD6bBZMcPOGO works to ensure that everyone affected by childhood...
- MAIA Biotechnology Delivers Oral and Poster Presentations Showcasing Next-Generation Telomere-Targeting Cancer Therapies at IRT 2026Next-generation divalent agents show increased anticancer activity in preclinical in vitro and in vivo models
- Oncolytics Biotech® Announces Positive Preclinical Results Combining Pelareorep with a Pan-RAS Inhibitor in Colorectal CancerOncolytics announced positive preclinical results evaluating pelareorep in combination with a pan-RAS inhibitor in a RAS-driven colorectal cancer model.
- Consano BioConsano Bio Announces Peer-Reviewed Publication Supporting the Therapeutic Potential of C-1101 in Chronic, Painful Lumbosacral Radiculopathy (LSR) or Chronic SciaticaResearch published in Frontiers in Bioengineering and Biotechnology demonstrated C‑1101 reduced inflammation and tissue breakdown while activating repair pathways — acting on the disease, not just the pain — in a nonclinical study Pain sensitivity also decreased in a second species,...